Skip to main content
. 2006 Feb;168(2):597–607. doi: 10.2353/ajpath.2006.050620

Figure 3.

Figure 3

Down-regulation of CSR1 expression and methylation of CSR1 promoter is associated with decrease of PSA-free survival. A: Kaplan-Meier curve of PSA-free survival based on immunostaining of CSR1 in prostate cancer samples. Prostate cancer samples were divided into CSR ≥1 or ≤0.5. B: Kaplan-Meier curve of PSA-free survival based on the methylation status of the CSR1 promoter.